A 3H+-release method has been developed for the assay of P-hydroxylation of the adrenolytic drug mitotane. P-3H-rnitotane was synthesized by the reduction of 142-chlorophenyl)-l-(4-chlorophenyl)-2,2,2-trichloroethane by an aluminium-HgZC12 couple in the presence of 3Hz0. For P-hydroxylation of mitotane, the jH+-release assay is more efficient and sensitive than a method utilizing 14C-mitotane and chromatographic separation of metabolites by HPLC. The 3H+-release assay has been used to evaluate the ability of adrenal tumors to metabolize mitotane via the Phydroxylation route.
INTRODUCTION
Mitotane (o,p'-DDD) is used for the treatment of adrenal carcinoma and Cushing's disease (1.2) . In regard to the biochemical mechanism of action by which mitotane causes its adrenolytic effect or interferes with steroid synthesis, our studies to date (3) and the *Address correspondence to: J.E. Sinsheimer, 1028 College of Pharmacy, The University of Michigan, Ann Arbor, MI 48109-1065.
literature indicate that a mitochondrial cytochrome P-450 is involved in mitotane metabolic transformations (4). We have previously identified o,p'-DDA as a major metabolite of mitotane ( 5 ) and proposed (3) its formation by a P450-catalyzed hydroxylation of mitotane at the 0-carbon to give an unstable gem dichlorohydroxyrnethyl metabolite. Subsequent dehydrochlorination of the hydroxylated product will form the corresponding acyl chloride that, in the presence of water, will form the acidic metabolite, o,p'-DDA, or could bind to tissue nucleophiles ( Fig. 1 ). To further study the role of P-hydroxylation in the activation of mitotane, the enzyme(s) involved in this metabolic route and to evaluate the ability of adrenal tumors to activate mitotane via P-hydroxylation, a rapid and specific assay for the P-hydroxylation of mitotane has been developed. The method is comparable to the 3H-release method developed for the assay of aromatase (6.7) and lanosterol 14a-demethylase (8) in which a P450-catalyzed oxidative reaction results in the oxidation of a specific C-H bond releasing the hydrogen atom to the solvent medium as a proton. After organic solvent extraction of the unreacted substrate the amount of 3H+ released to the aqueous media can be readily determined.
RESULTS AND DISCUSSION
The reaction conditions required to label mitotane at the desired position were developed using deuterated reagents and evaluation of the reaction products by 1H-NMR.
Synthesis of P-3H-Mitotane
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Attempts to deuterate the p-position by the addition of 2H20 to a reaction of mitotane and n-butyllithium (9) or by selective reduction of the iodo group from P-I-o,p'-DDD were unsuccessful. In the former reaction, only low incorporation of deuterium was achieved in a process where labelled mitotane could not be separated from starting mitotane. In the second approach, reaction of P-I-o,p'-DDD with NaCNBH3 resulted
The successful synthesis of P-3H-o,pf-DDD was based upon the approach used by is also an indication of the stability of the 3H-C bond.
The validity of using 3H+-release from P-3H-mitotane in assays for mitotane metabolism was examined by comparing the results of this method with that of the literature for the subcellular distribution of mitotane metabolism in dog and bovine adrenal cortex preparations (1 1,12 Table 1 , the results for mitotane metabolism using the 3H-release assay were also compared to incubations with
pCltmmo1) (13) using a 14C-HPLC assay (14) . The activities determined with the 3H-release assay correlated well with the values obtained with the 14C-HPLC assay when both free and bound metabolites are considered for the latter method. Based upon our hypothesis that mitotane requires metabolic activation to act as an adrenolytic agent, it is clinically important to establish the ability of human adrenal tumors to metabolize mitotane. The 3H-release assay provides a more efficient and sensitive method than the 14C-HPLC assay to monitor the capacity of adrenal tumors to promote P-oxidation of mitotane. That is, a major advantage of the 3H-release method to measure mitotane metabolism is the rapidity of the assay. For example, a typical assay utilizing the 3H-release method took between 2-3 hrs for completion and between 20-40 reactions can be processed in a single experiment. In contrast the l4CC-HPLC assay previously used required two days to process four samples. In addition, there is a significant increase in the sensitivity of the 3H-release assay due to the higher specific activity readily obtainable for the 3H-reagent versus a 14C-mitotane reagent. 
EXPERIMENTAL
1-(2-CNorophenyl)-1-(4-chloropheny1)-2,2-dichloro-2-iodoethane (p-I-o,p '-
DDD): Diisopropylamine (0.5 mL, 3.4 mmol) was added to a reaction flask containing dry THF (3.3 mL) and anhydrous ether (6.7 mL) under a nitrogen atmosphere at -5°C. nButyllithium (1.72 mL, 3.4 mmol) was added and after 10 min the temperature was lowered to -78°C (dry icelacetone). After 30 min, mitotane (1.0 g, 3.13 mmol) dissolved in ether (6.7 mL) was added dropwise to the cooled reaction mixture. The reaction was stirred for an additional 50 min followed by addition of n-iodosuccinimide (1.5 g, 6.7 mmol) in THF (5 mL). After 15 min, the reaction was quenched by the slow addition of distilled water (2 mL). The reaction mixture was allowed to warm up to room temperature and hydrochloric acid (1 .O N, 2 mL) was added. The layers were separated and the remaining aqueous phase was extracted with ether (3 x 10 mL). The crude product was purified by column chromatography (silica with hexane Table 1 , in a final volume of 1 mL. The reaction was started by the addition of NADP+ and samples were incubated for 20 min. The reaction was stopped by addition of 5 mL of chloroform to each tube and tubes were vigorously mixed for 1 min and then centrifuged for 10 min at 3000xg. An aliquot of the aqueous phase ice for 25 min and then centrifuged for 10 min. An 800-pL aliquot was removed and added to 6.5 mL of Ecolite scintillation fluid and counted with an LS 5000 scintillation counter. Results were expressed as pmol/min/mg protein or percent transformation.
